Find News

Filter articles

Showing 3911 to 3920 of 3962 results

Amgen and Astellas join forces in Japan

Japan, US30-05-2013

California-based biotechnology company Amgen has entered into a long-term partnership with Japanese pharmaceutical company Astellas Pharmas Inc to provide new medicines in Japan.

Patents covering IVF test spark row


Members of the scientific community have blasted Stanford University and US biotechnology company Auxogyn for their involvement in patenting a test designed to increase the success of in vitro fertilisation (IVF).

Hi-tech and life sciences dominate at EPO awards


The inventor of the world’s first flat-panel liquid crystal display, Martin Schadt, was among a number of winners at the European Patent Office European Inventor Award 2013.

WHO issues IP warning over MERS virus


The World Health Organization has warned that “no IP will stand in the way of public health actions” amid the spreading of a deadly global virus.

Actavis to buy Warner Chilcott

Ireland, US22-05-2013

Actavis announced on May 20 it will acquire specialty pharmaceutical company Warner Chilcott plc in a deal worth an estimated $5 billion.

Supreme Court to hear Medtronic case


The US Supreme Court has agreed to hear a patent infringement case between medical device manufacturers Medtronic and Boston Scientific.

RuiYi joins with Genor to develop cancer treatment

China, US20-05-2013

San Diego-Shanghai biotechnology startup RuiYi Inc has entered into an exclusive license and collaborative development agreement with Shanghai-based Genor BioPharma to develop the RYI-008 molecule in China.

Ideas Matter: the importance of IP in the fight against cancer


On May 14, healthcare experts met in London to share and discuss developments in cancer detection, prevention, treatment and maintenance, and how IP protection and management are vital in attracting investment.

Ideas Matter: Philips and Microsoft in life sciences


At the Ideas Matter roundtable last week LSIPR spoke to Maaike van Velzen, general manager of Philips Group Innovation’s IP and Standards division, about the importance of using IP to promote the company’s vision.

IP key to US biosimilars success – report


Strong IP knowledge is one of four key factors to succeeding in the burgeoning US biosimilars market, according to an industry report.

Showing 3911 to 3920 of 3962 results